Johns Hopkins Outpatient Center
Baltimore, Maryland, United States
Hospital department in Baltimore, Maryland
601 N Caroline St, Baltimore, MD 21287
About Johns Hopkins Outpatient Center
"For convenient access to appointments in The Johns Hopkins Outpatient Center, please park in the McElderry Street Garage."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Johns Hopkins University
15
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
7
Cytokinetics
2
Advanced Accelerator Applications
1
Bayer
1
Becton, Dickinson and Company
1
Ferring Pharmaceuticals
1
Mallinckrodt
1
Novartis Pharmaceuticals
1
Pfizer
1
Transposon Therapeutics, Inc.
1
Clinical Trials at Johns Hopkins Outpatient Center
During the past decade, Johns Hopkins Outpatient Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 7 clinical trials were completed, i.e. on
average, 31.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability
2008-01-01
2011-06-01
Terminated
31
Incidence of Proximal Junctional Kyphosis (PJK) in Long Posterior Spinal Fusion: A Study Comparing Traditional Open Surgery to Minimally Invasive Percutaneous Technique at the Proximal Fusion Levels
2009-06-01
2017-07-01
Completed
48
Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)
2009-09-01
2016-07-01
Completed
132
An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
2007-01-16
2020-02-12
Completed
894
Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer
2011-05-01
2014-12-01
Completed
4
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
2011-12-01
2014-03-01
Completed
183
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Johns Hopkins Outpatient Center" #1 sponsor was "Johns Hopkins University" with 15 trials, followed by "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 7 trials
sponsored, "Cytokinetics" with 2 trials sponsored, "Advanced Accelerator Applications" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Outpatient Center"
#1 collaborator was "Duke University" with 1 trials as a collaborator, "Frantz Viral Therapeutics" with 1 trials as a collaborator, "Frantz Viral Therapeutics, LLC" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Johns Hopkins Outpatient Center
According to Clinical.Site data, the most researched conditions in "Johns Hopkins Outpatient Center" are
"Amyotrophic Lateral Sclerosis" (5 trials), "Breast Cancer" (2 trials), "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Articular Cartilage Defect" (1 trials) and "Articular Cartilage Disorder of Knee" (1 trials). Many other conditions were trialed in "Johns Hopkins Outpatient Center" in a lesser frequency.
Clinical Trials Intervention Types at Johns Hopkins Outpatient Center
Most popular intervention types in "Johns Hopkins Outpatient Center" are "Drug" (16 trials), "Device" (7 trials), "Other" (6 trials), "Procedure" (5 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Reldesemtiv" (2 trials), "177Lu-DOTA0-Tyr3-Octreotate" (1 trials), "18F-DCFBC" (1 trials) and "18GA Conventional Catheter" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Johns Hopkins Outpatient Center
The vast majority of trials in "Johns Hopkins Outpatient Center" are
23 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Johns Hopkins Outpatient Center
Currently, there are NaN active trials in "Johns Hopkins Outpatient Center".
undefined are not yet recruiting,
4 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in Johns Hopkins Outpatient Center,
1 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Outpatient Center, 6 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 11 trials that are defined as “Not Applicable".